Table of Contents
1 Cancer Supportive Care Drugs Market Overview
1.1 Product Overview and Scope of Cancer Supportive Care Drugs
1.2 Classification of Cancer Supportive Care Drugs by Types
1.2.1 Global Cancer Supportive Care Drugs Revenue Comparison by Types (2019-2024)
1.2.2 Global Cancer Supportive Care Drugs Revenue Market Share by Types in 2018
1.2.3 G-CSFs (Granulocyte-colony Stimulating Factors)
1.2.4 ESAs (Erythropoiesis Stimulating Agents)
1.2.5 Anti-emetics
1.2.6 Bisphosphonates
1.2.7 Opioids
1.2.8 NSAIDs
1.3 Global Cancer Supportive Care Drugs Market by Application
1.3.1 Global Cancer Supportive Care Drugs Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Chemotherapy Therapy
1.3.3 Radiation Therapy
1.4 Global Cancer Supportive Care Drugs Market by Regions
1.4.1 Global Cancer Supportive Care Drugs Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Cancer Supportive Care Drugs Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Cancer Supportive Care Drugs Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cancer Supportive Care Drugs Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Cancer Supportive Care Drugs Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cancer Supportive Care Drugs Status and Prospect (2014-2024)
1.5 Global Market Size of Cancer Supportive Care Drugs (2014-2024)
2 Company Profiles
2.1 Tesaro
2.1.1 Business Overview
2.1.2 Cancer Supportive Care Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Tesaro Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.2 Roche
2.2.1 Business Overview
2.2.2 Cancer Supportive Care Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Roche Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.3 Johnson & Johnson
2.3.1 Business Overview
2.3.2 Cancer Supportive Care Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Johnson & Johnson Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.4 Amgen
2.4.1 Business Overview
2.4.2 Cancer Supportive Care Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Amgen Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.5 Merck
2.5.1 Business Overview
2.5.2 Cancer Supportive Care Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Merck Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.6 Heron Pharma
2.6.1 Business Overview
2.6.2 Cancer Supportive Care Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Heron Pharma Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.7 Helsinn Healthcare
2.7.1 Business Overview
2.7.2 Cancer Supportive Care Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Helsinn Healthcare Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2017-2018)
3 Global Cancer Supportive Care Drugs Market Competition, by Players
3.1 Global Cancer Supportive Care Drugs Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Cancer Supportive Care Drugs Players Market Share
3.2.2 Top 10 Cancer Supportive Care Drugs Players Market Share
3.3 Market Competition Trend
4 Global Cancer Supportive Care Drugs Market Size by Regions
4.1 Global Cancer Supportive Care Drugs Revenue and Market Share by Regions
4.2 North America Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
4.3 Europe Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
4.5 South America Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
5 North America Cancer Supportive Care Drugs Revenue by Countries
5.1 North America Cancer Supportive Care Drugs Revenue by Countries (2014-2019)
5.2 USA Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
5.3 Canada Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
5.4 Mexico Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
6 Europe Cancer Supportive Care Drugs Revenue by Countries
6.1 Europe Cancer Supportive Care Drugs Revenue by Countries (2014-2019)
6.2 Germany Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
6.3 UK Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
6.4 France Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
6.5 Russia Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
6.6 Italy Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Cancer Supportive Care Drugs Revenue by Countries
7.1 Asia-Pacific Cancer Supportive Care Drugs Revenue by Countries (2014-2019)
7.2 China Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
7.3 Japan Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
7.4 Korea Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
7.5 India Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
8 South America Cancer Supportive Care Drugs Revenue by Countries
8.1 South America Cancer Supportive Care Drugs Revenue by Countries (2014-2019)
8.2 Brazil Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
8.3 Argentina Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
8.4 Colombia Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Cancer Supportive Care Drugs by Countries
9.1 Middle East and Africa Cancer Supportive Care Drugs Revenue by Countries (2014-2019)
9.2 Saudi Arabia Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
9.3 UAE Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
9.4 Egypt Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
9.5 Nigeria Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
9.6 South Africa Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
10 Global Cancer Supportive Care Drugs Market Segment by Type
10.1 Global Cancer Supportive Care Drugs Revenue and Market Share by Type (2014-2019)
10.2 Global Cancer Supportive Care Drugs Market Forecast by Type (2019-2024)
10.3 G-CSFs (Granulocyte-colony Stimulating Factors) Revenue Growth Rate (2014-2024)
10.4 ESAs (Erythropoiesis Stimulating Agents) Revenue Growth Rate (2014-2024)
10.5 Anti-emetics Revenue Growth Rate (2014-2024)
10.6 Bisphosphonates Revenue Growth Rate (2014-2024)
10.7 Opioids Revenue Growth Rate (2014-2024)
10.8 NSAIDs Revenue Growth Rate (2014-2024)
11 Global Cancer Supportive Care Drugs Market Segment by Application
11.1 Global Cancer Supportive Care Drugs Revenue Market Share by Application (2014-2019)
11.2 Cancer Supportive Care Drugs Market Forecast by Application (2019-2024)
11.3 Chemotherapy Therapy Revenue Growth (2014-2019)
11.4 Radiation Therapy Revenue Growth (2014-2019)
12 Global Cancer Supportive Care Drugs Market Size Forecast (2019-2024)
12.1 Global Cancer Supportive Care Drugs Market Size Forecast (2019-2024)
12.2 Global Cancer Supportive Care Drugs Market Forecast by Regions (2019-2024)
12.3 North America Cancer Supportive Care Drugs Revenue Market Forecast (2019-2024)
12.4 Europe Cancer Supportive Care Drugs Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Cancer Supportive Care Drugs Revenue Market Forecast (2019-2024)
12.6 South America Cancer Supportive Care Drugs Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Cancer Supportive Care Drugs Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Cancer Supportive Care Drugs Picture
Table Product Specifications of Cancer Supportive Care Drugs
Table Global Cancer Supportive Care Drugs and Revenue (Million USD) Market Split by Product Type
Figure Global Cancer Supportive Care Drugs Revenue Market Share by Types in 2018
Figure G-CSFs (Granulocyte-colony Stimulating Factors) Picture
Figure ESAs (Erythropoiesis Stimulating Agents) Picture
Figure Anti-emetics Picture
Figure Bisphosphonates Picture
Figure Opioids Picture
Figure NSAIDs Picture
Table Global Cancer Supportive Care Drugs Revenue (Million USD) by Application (2014-2024)
Figure Cancer Supportive Care Drugs Revenue Market Share by Applications in 2018
Figure Chemotherapy Therapy Picture
Figure Radiation Therapy Picture
Table Global Market Cancer Supportive Care Drugs Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Cancer Supportive Care Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Cancer Supportive Care Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Cancer Supportive Care Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Cancer Supportive Care Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Cancer Supportive Care Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Cancer Supportive Care Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Table Tesaro Basic Information, Manufacturing Base and Competitors
Table Tesaro Cancer Supportive Care Drugs Type and Applications
Table Tesaro Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Cancer Supportive Care Drugs Type and Applications
Table Roche Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Cancer Supportive Care Drugs Type and Applications
Table Johnson & Johnson Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Cancer Supportive Care Drugs Type and Applications
Table Amgen Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Cancer Supportive Care Drugs Type and Applications
Table Merck Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Heron Pharma Basic Information, Manufacturing Base and Competitors
Table Heron Pharma Cancer Supportive Care Drugs Type and Applications
Table Heron Pharma Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Helsinn Healthcare Basic Information, Manufacturing Base and Competitors
Table Helsinn Healthcare Cancer Supportive Care Drugs Type and Applications
Table Helsinn Healthcare Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Global Cancer Supportive Care Drugs Revenue (Million USD) by Players (2014-2019)
Table Global Cancer Supportive Care Drugs Revenue Share by Players (2014-2019)
Figure Global Cancer Supportive Care Drugs Revenue Share by Players in 2017
Figure Global Cancer Supportive Care Drugs Revenue Share by Players in 2018
Figure Global Top 5 Players Cancer Supportive Care Drugs Revenue Market Share in 2018
Figure Global Top 10 Players Cancer Supportive Care Drugs Revenue Market Share in 2018
Figure Global Cancer Supportive Care Drugs Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Cancer Supportive Care Drugs Revenue (Million USD) by Regions (2014-2019)
Table Global Cancer Supportive Care Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Cancer Supportive Care Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Cancer Supportive Care Drugs Revenue Market Share by Regions in 2018
Figure North America Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Figure Europe Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Figure South America Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Table North America Cancer Supportive Care Drugs Revenue by Countries (2014-2019)
Table North America Cancer Supportive Care Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Cancer Supportive Care Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Cancer Supportive Care Drugs Revenue Market Share by Countries in 2018
Figure USA Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Figure Canada Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Figure Mexico Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Table Europe Cancer Supportive Care Drugs Revenue (Million USD) by Countries (2014-2019)
Figure Europe Cancer Supportive Care Drugs Revenue Market Share by Countries (2014-2019)
Figure Europe Cancer Supportive Care Drugs Revenue Market Share by Countries in 2018
Figure Germany Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Figure UK Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Figure France Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Figure Russia Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Figure Italy Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Cancer Supportive Care Drugs Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Cancer Supportive Care Drugs Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Cancer Supportive Care Drugs Revenue Market Share by Countries in 2018
Figure China Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Figure Japan Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Figure Korea Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Figure India Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Table South America Cancer Supportive Care Drugs Revenue by Countries (2014-2019)
Table South America Cancer Supportive Care Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Cancer Supportive Care Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Cancer Supportive Care Drugs Revenue Market Share by Countries in 2018
Figure Brazil Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Figure Argentina Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Figure Colombia Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Cancer Supportive Care Drugs Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Cancer Supportive Care Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Cancer Supportive Care Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Cancer Supportive Care Drugs Revenue Market Share by Countries in 2018
Figure Saudi Arabia Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Figure UAE Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Figure Egypt Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Figure Nigeria Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Figure South Africa Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Table Global Cancer Supportive Care Drugs Revenue (Million USD) by Type (2014-2019)
Table Global Cancer Supportive Care Drugs Revenue Share by Type (2014-2019)
Figure Global Cancer Supportive Care Drugs Revenue Share by Type (2014-2019)
Figure Global Cancer Supportive Care Drugs Revenue Share by Type in 2018
Table Global Cancer Supportive Care Drugs Revenue Forecast by Type (2019-2024)
Figure Global Cancer Supportive Care Drugs Market Share Forecast by Type (2019-2024)
Figure Global G-CSFs (Granulocyte-colony Stimulating Factors) Revenue Growth Rate (2014-2019)
Figure Global ESAs (Erythropoiesis Stimulating Agents) Revenue Growth Rate (2014-2019)
Figure Global Anti-emetics Revenue Growth Rate (2014-2019)
Figure Global Bisphosphonates Revenue Growth Rate (2014-2019)
Figure Global Opioids Revenue Growth Rate (2014-2019)
Figure Global NSAIDs Revenue Growth Rate (2014-2019)
Table Global Cancer Supportive Care Drugs Revenue by Application (2014-2019)
Table Global Cancer Supportive Care Drugs Revenue Share by Application (2014-2019)
Figure Global Cancer Supportive Care Drugs Revenue Share by Application (2014-2019)
Figure Global Cancer Supportive Care Drugs Revenue Share by Application in 2018
Table Global Cancer Supportive Care Drugs Revenue Forecast by Application (2019-2024)
Figure Global Cancer Supportive Care Drugs Market Share Forecast by Application (2019-2024)
Figure Global Chemotherapy Therapy Revenue Growth Rate (2014-2019)
Figure Global Radiation Therapy Revenue Growth Rate (2014-2019)
Figure Global Cancer Supportive Care Drugs Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Cancer Supportive Care Drugs Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Cancer Supportive Care Drugs Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Cancer Supportive Care Drugs Revenue Market Forecast (2019-2024)
Figure Europe Cancer Supportive Care Drugs Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Cancer Supportive Care Drugs Revenue Market Forecast (2019-2024)
Figure South America Cancer Supportive Care Drugs Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Cancer Supportive Care Drugs Revenue Market Forecast (2019-2024)
【掲載企業】
Tesaro、 Roche、 Johnson & Johnson、 Amgen、 Merck、 Heron Pharma、 Helsinn Healthcare
【免責事項】
https://www.globalresearch.jp/disclaimer